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Abstract
Background: There is growing interest in the collection, storage and reuse of biological samples for future
research. Storage and future use of biological samples raise ethical concerns and questions about approaches that
safeguard the interests of participants. The situation is further complicated in Africa where there is a general lack of
governing ethical frameworks that could guide the research community on appropriate approaches for sample
storage and use. Furthermore, there is limited empirical data to guide development of such frameworks. A
qualitative study to address this gap was conducted with key stakeholders in Malawi to understand their
experiences and perspectives regarding storage and usage of samples for future research.
Methods: This study conducted 13 in-depth interviews with ethics committee members, regulators and researchers,
and five focus group discussions with community representatives and clinical trial participants in Malawi. Interviews
and focus group discussions were audio-recorded, transcribed verbatim, and thematically analysed.
Results: On the current regulatory guidelines that governs the collection, storage and reuse of samples in Malawi,
participants highlighted their different understanding of it, with some indicating that it prohibited the reuse and
sharing of samples, while others believed it permitted.
Views on the informed consent model used in Malawi, some stakeholders expressed that the current model limited
options for sample contributors regarding future use. Researchers supported storing samples for future use in order to
maximize their value and reduce research costs. However, they expressed concern over the exportation of samples
highlighting that it could lead to misuse and would not support the development of research capacity within Malawi.
They recommended use of broad consent or tiered consent and establishment of biobanks to address these concerns.
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Conclusions: Study findings highlighted the need for a review of the current regulatory guideline and the
development of infrastructure to support the use of stored biological samples for future use among the research
community in Malawi. At the moment, there are ethical and practical concerns arising from the collection, storage and
secondary use of biological samples make it hard to reconcile scientific progress and the protection of participants.
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Background
Human biological samples, such as tissues, organs,
blood, cells and DNA, have been critical for global ad-
vances in biomedical research and population health [1].
For this reason, it has become an acceptable practice in
the scientific community that samples and data should
be made available for researchers [2, 3].
Samples and data collected in low middle income coun-
tries (LMIC) are sometimes exported to high income
countries (HICs) for analysis due to a number of reasons
including; lack of resources, lack of technical capacity, and
lack of infrastructure like laboratories [4]. Increased devel-
opment in biotechnology creates demand of reuse of sam-
ples and data in LMIC. In the past decade, Malawi has
experienced tremendous growth in hosting research and
researchers, collaborating with sponsors and funders from
high Income countries (HIC). This has inevitably led to
the collection and storage of samples for future research
with some left-over samples exported to HICs for unspeci-
fied future research [3].
Exporting and sharing of samples and data from
LMICs brings ethical challenges. For example, there
are questions regarding specific mechanisms that are
employed to safeguard the interests of research par-
ticipants such as sample donors, [2] and appropriate
models of consent for sample storage and reuse.
There are also concerns about how to share research
benefits in a way that is fair and acceptable to partici-
pants, their communities and funders [2–4].
Biobanking
Biobanks are repositories for the organized collection of
human biological samples, with associated personal
health information [5]. The establishment of biobanks in
LMICs has received significant support during the past
decade as it has been viewed as the best way to build
local research capacity and facilitate the rapid delivery of
research findings. In Africa, biobanks have been pro-
moted by the Human, Health and Heredity in Africa
(H3Africa) group [6], which is a consortium of African
scientists funded by the Wellcome Trust and the US Na-
tional Institutes of Health (NIH) in partnership with the
African Society for Human Genetics. H3Africa aims to
promote genomic research expertise on the African
continent with the aim of using genomic methods to ad-
dress health inequities in both communicable and non-
communicable diseases [4]. As part of its work, the
H3Africa consortium has supported development of
biorepositories in Nigeria, Uganda and South Africa. Set-
ting up biobanks minimizes exporting samples from
LMICs to HICS [7]. Samples can be stored and be used
in future research in their countries of origin, thereby
tackling the ethical challenges associated with export-
ation of samples to HICs and sample misuse [7]. Overall,
genomics and biobanking have shifted the way research
is done since it allows openness, data sharing, collabor-
ation of scientists in LMICs and HICs and reuse of sam-
ples for future unspecified research [7].
The drive to establish biobanks in Africa is a positive
initiative. However, there remain gaps in research gov-
ernance, oversight practices and regulatory guidance on
consenting procedures for the collection, storage and re-
use of samples for future research. For instance, a study
done in Kenya in 2005 reported that 25% of protocols
reviewed indicated the requirement for sample storage
and use, but only half of the studies informed research
participants about sample storage and future use during
the consenting process [2]. These findings point to the
ethical concerns related with biobanking including other
relevant concerns such as governance, community engage-
ment, international collaboration and sample sharing [8].
The role of regulatory authorities and ethics committees
National Research Ethics Committees (NRECs) and Na-
tional Regulatory Boards (NRBs) are mandated to safe-
guard the rights and welfare of research participants, by
ensuring that ethical challenges that are present in re-
search are mitigated and that researchers scrupulously
follow ethical principles and frameworks [9].
In Malawi, Research Ethics Committee (RECs) such as
the National Health Sciences Research Ethics Committee
(NHSRC), the Malawi University of Science and Tech-
nology Research Ethics Committee (MUSTREC), the
College of Medicine Research Ethics Committee (COM-
REC) as well as the National Commission for Science
and Technology (NCST), which is the national regula-
tory board (mandated to promote and regulate the con-
duct of research in Malawi), have adopted policies,
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guidelines and ethical principles to ensure that research
participants’ interests are safeguarded. However, imple-
mentation of these policies remain a challenge [8]. In
view of this, in 2012 an NCST statement stopped the
storage and future use of biological samples for unspeci-
fied research. Therefore, this policy statement motivated
this research study that aimed at exploring views of key
research stakeholders on the collection, storage and fu-
ture use of biological samples for unspecified research.
This study firstly explored ethical issues surrounding the
collection, storage and use of human biological samples
from LMICs in future unspecified research. Secondly,
the study examined views on informed consent models
for collection and reuse. Finally, views and perspectives
of different stakeholders on biobanking as well its bene-
fits and challenges were documented.
Aims and methods
This study aimed to explore experiences, views and prac-
tices of critical stakeholders (thus ethics committee mem-
bers, regulators, researchers, community representatives
and research participants) regarding sample collection,
storage and reuse, as well as consent models currently in
use in Malawi. The study covered a 6-month period from
May to October 2018.
We conducted a total of 13 In-Depth Interviews (IDI) with
purposively selected key informants identified from institu-
tions that are extensively involved in clinical research that
collect, store and use human biological samples. We sampled
a diverse group of key informants with a purpose of maxi-
mizing diversity of research experience and research themes.
We conducted three IDIs each with REC members and na-
tional regulatory board personnel, and seven IDIs with re-
searchers from six different research institutions in Lilongwe
and Blantyre. A total of five Focus Group Discussions (FGD)
were conducted in chichewa; three of them with clinical tri-
als research participants from Chikwawa, Lilongwe and Kar-
onga districts and two with Community Advisory Board
(CAB) members in Lilongwe and Karonga respectively. Each
FGD had between eight to 10 homogenous participants. The
number of participants were limited to 10 to ensure active
participation [10], refer to Table 1.
For FGDs, we approached people that were enrolled
in clinical trials at the time of our research and had
donated samples as part of their research procedures.
Through research sensitization/education sessions,
administrative staff and research nurses from the par-
ticipating institutions informed clinical trial partici-
pants about the study and briefed them about our
study objectives. Those who voluntarily agreed to par-
ticipate in the study were recruited and requested to
come on the next day for an FGD. To recruit CAB
members, respective research institutions first briefed
CAB members about the study during their CAB
meetings. Following their willingness to participate in
the FGDs, CAB members were called for a discussion
on an agreed date.
IDIs were guided by open ended questions based on
an interview guide that was revised throughout the study
in consensus with the researchers following the induct-
ive approach. Questions were revised on the basis of
participants’ experiences and responses that required
further assessment. Data collection was stopped when
saturation was achieved and no more relevant themes
were being identified [10].
All interviews were recorded, translated and tran-
scribed verbatim. The interview transcripts were ana-
lysed using Thematic Content Analysis [11]. Data was
coded with inductive descriptive codes generated from
the interview transcripts. Themes emerging from the
data were discussed among the investigators and coding
differences were resolved by reaching a consensus [12],
refer to Table 2. Data was managed with NVivo 12.0.
College of Medicine Research and Ethics Committee
(CoMREC) reviewed and approved the study. Its ethics
reference number is P08/17/1233. Institutional permis-
sions were sought from all participating institutions and
their letters of support were submitted to the CoMREC
prior to the interviews, written individual consent was
obtained from all research participants who participated
in either the FGDs or IDIs.
Table 1 Characteristics of study participants
Data collection method Group/Key Informant Number of IDIs/FGDs Number of participants
IDI REC members 3 3
IDI National regulatory board personnel 2 2
IDI Researchers 8 8
Total participants in IDIs 13
FGD Research participants 3 24
FGD CAB members 2 23
Total participants in FGDs 47
Total number of participants in the whole study 60
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Results
Each of the theme is discussed below.
Experiences and concerns with collection, storage and
use of biological samples for research
IDIs with researchers and REC members revealed a
number of experiences regarding collection, storage and
use of biological samples for research in Malawi. Both
researchers and REC members acknowledged that the
current practice does not permit the collection of bio-
logical samples for future research purposes as explained
by the participant below:
"The current policy is to discard the leftover sample.
The collection, and the shipment can still be done
but under a material transfer agreement. After all
that, after a specific period, let’s say the first 5 years,
discard, although l personally have problems with
that. l would say it was a wrong practice because
that was not a regulated policy, it’s simply a
practice". (IDI 234, Regulator).
In addition, the practice of sending samples to institu-
tions outside Malawi for further analysis was a concern.
REC members concurred with researchers on concerns
about their inability to control what happens to exported
samples as expressed below.
"… since we do not have control for operations
happening outside the country but we know that
some samples are still being kept coming from
Malawi under the pretext of lack of capacity in
Malawi, but these are research institutions that have
been here for some time, some more than 20 years,
25 years, but still more there is no capacity to
conduct some tests. Yes, some are complicated and
will call for exportation but some are not compli-
cated and by now Malawi could have had capacity
to manage or do tests on those samples". (IDI 221,
REC Member).
It was further revealed that fear that samples may be
sold and misused were some of the reasons that trig-
gered the release of the guidelines stipulating Malawi’s
stand on prohibiting the use of biological samples for fu-
ture research.
"… . people have no idea why they are collecting the
specimens and sometimes they can sell those speci-
mens or use to discover something, make money out
of it, patent it, and not acknowledge where it come
from and ripe all the benefits. (IDI 232, REC
Member).
Another concern was lack of clear guidelines to offer
guidance to researchers on how to destroy left over sam-
ples that are shipped outside of Malawi.
"… even the specimens that are collected and sent
outside, we fill an MTA (Material Transfer Agreement),
investigators fill-in MTAs but there is no indication in
the guidelines. Material transfer agreements are not
actually covered in the guidelines. They are there, just
documents to fill-in. And so the investigator sends
specimen outside, they promise to destroy and there is no
follow-up to say have those specimens been destroyed.
How? We just believe that ok they will be destroyed? The
guidelines are silent on that (IDI 232, REC Member).
Benefits of re-use of samples
Researchers expressed support for reuse of samples for
future unspecified research by specifically indicating that
such practice helps to lessen the cost and time burdens
on researchers.
"I tell you, it can be better for master students, everybody
wants to collect fresh data, yet it is very expensive. We
are poor in Malawi and some other bright people fail to
do good studies because they are looking for money to go
recruit people to collect samples. If we had a biobank
associated with the data for those individuals, I think
our master’s students and PhD students would look at
what data is there and analyze it or maybe do one
additional test and they would have the other results
ready. I think it’s important for Malawi. It would
actually make our research more efficient and get more
people do more research by using available data and
samples" (IDI 224, Researcher).
"The benefits are that they allow you to use data
from a defined clinical trial cohort to better leverage
information from that cohort. You wouldn’t be able
to ever recreate that same cohort because it is
expensive". (IDI 226, Researcher).
Table 2 A Summary of seven major themes derived from the
interviews
Themes
Experiences and concerns with the current practice of collecting, storing
and using samples in Malawi
Benefits of reusing samples
Perception on biobanking
Ethical Challenges of setting up biobanks in Malawi
Views on current informed consent models
Concerns over specific informed consent
Views on research governance and oversight
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Perceptions on biobanks
REC members, researchers and research participants
were asked about their perceptions on the establishment
of a biobank in Malawi. Most of them were concerned
about access to samples by other researchers and how
feedback to the community would be provided. Add-
itionally, REC members and researchers expressed con-
cerns over the lack of proper consenting guidelines on
sample ownership and poor governance frameworks to
support the monitoring of researchers who collect and
store samples.
"… we need to have access to the storage facility for
us to know how the samples are kept. Furthermore,
the results need to be given to the participants. They
may collect samples but they have to know that
feedback is very important. You need to be aware of
any problem/disease that you have been diagnosed
with for you to take action". (FGD 441 with Research
Participants).
One REC member’s concern about ownership of col-
lected samples was put like this:
"...of course the other tricky thing is who owns these
specimens if the patient has donated or you have
collected those samples? … is it Malawi government,
is it the research, it is the research institution, it is
still the patient in such a way that you have to come
back to the patient to ask for another consent for
future research? In the guidelines and in the
framework, there has to be an issue to do with
ownership." (IDI 221, REC Member).
The concern expressed above is related to the lack
of clear consenting guidelines in Malawi for storage
and future use of samples. One researcher echoed this
concern stating that there appears to be no ethics
governance in place to compel researchers to declare
what samples they have kept and what samples have
been destroyed.
"I think in my experience, there has never been a
time where someone has come to me to ask for
sample that I collected for some study and ask
me where the samples are. I think the ethics
committee believes that after five years have
gone, then we have destroyed the samples. I must
say that there is no kind of inspection to see that
indeed the samples were destroyed". (IDI 224,
Researcher).
The above concerns point to the ethical concerns re-
lated to governance and oversight of stored samples.
Ethical challenges of setting up biobanks in Malawi
Researchers, REC members and study participants
were asked about the ethical challenges of setting up
biobank in Malawi. Study participants indicated an
interest to know how incidental findings will be com-
municated back to them and medically acted upon.
Research participants echoed that by providing bio-
logical samples, researchers are placed with a duty to
keep them informed on any issues related to their
health that will be identified at a later stage or in fu-
ture research.
"In my opinion, they have tested maybe cough, or
headache, they should tell me what disease has been
found in me. The same when they have tested you
for any disease, they should tell you". (FDG 440,
Clinical trial participants).
Study participants questioned why samples could be
kept for future research without much details to share
with them on how their samples would be used.
"My fear is taking my blood today and use it next
year". (FGD 440, clinical trial participants,)
"… same with me, the period between blood giving
and use is long, so we would want to hear concrete
reasons why they are failing to tell us the actual
reason". (FGD 440, clinical trial participants,).
"...but also, we don’t get it when they say they are
going to use it after five years, will it be to our
knowledge or not?" (FGD 440, clinical trial
participants).
Researchers also highlighted the ethical concern of
sample sharing with other researchers. It was reported
that there is need for proper guidance on sharing and
access to samples.
… "What it takes to have your samples going to a
biobank for example, how long the samples can be
kept for and ahhh you know at what point those
samples are to be available to other researchers"
(IDI 222, Researcher).
CAB members cautioned researchers on some im-
portant considerations that ought to be followed for
ethical storage of their samples for research
purposes.
"They should be mindful that the samples belong to
the participants in a certain area; as such they have
to exercise confidentiality. They do not have to
publicize our results". (FGD 441, CAB members).
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Views on current informed consent models
The study also examined what respondents regarded to
be the most appropriate way of obtaining informed con-
sent for secondary collection, storage and reuse of sam-
ples for future research purposes.
According to researchers and REC members, specific
informed consent is permissible in Malawi. Researchers
reported having been specific during informed consent
processes by outlining what tests will be done in order
to answer the current approved research objectives.
However, some researchers reported challenges in
obtaining specific informed consent. For instance, in
pediatric and autopsy studies obtaining informed con-
sent procedures is very challenging as some guardians
consent while distressed. Researchers described informed
consent procedures conducted during this time as very
critical hence the need to use dynamic consent in order to
"maximize the return on the informed consent by answer-
ing as many scientifically relevant questions as possible
from a single case" (IDI 223, Researcher). Samples collected
from children and autopsy studies were regarded as pre-
cious resources taking into consideration the nature of the
consenting process and scarcity of such cases.
"We always have our informed consent form. Maybe I
should take a step back and say that the samples that
we often store for future use are from autopsies. … …
… somebody’s baby just died and you are asking them
to do an autopsy so it’s difficult to get consent, and
you know we want to maximize the return on that
consent and scientifically we want to get as much as
possible out of that one case. … We always try to be
specific in our questions. (IDI 223, Researcher).
Concerns over specific informed consent: Can’t we just
keep the samples?
Most researchers argued that even though Malawi has
restrictive policies on sample use for future research, the
practice of collecting samples and keeping them with the
expectation of using them for other research purposes in
future is ideal as such samples are regarded as very pre-
cious resources. They noted that samples could be used
for both academic and public health reasons in Malawi,
hence, keeping for re-use would maximize their utility.
However, the current specific informed consent model
restricts the use of samples beyond the current study
objectives.
"The thing is, it doesn’t allow you to do that. They
will give you consent only for the current approved
study. After you are done with that you discard
them. You do not keep them but if you haven’t fin-
ished, you can store them for only 5 years. If you
haven’t finished by that time because you still have
some things to do, within the current approved
protocol, you can also seek another approva … (IDI
230, Researcher).
There were views from the REC members that were
contrary to those of the researchers on the need to reuse
already collected samples. REC members recommended
the decision to disregard use of samples for other objec-
tives beyond the current approved study objectives.
"...it is a matter of safe guarding those specimens
isn’t it, so that people don’t use them anyhow (IDI
230, REC member).
Research participants reported that it was the obligation of
researchers to respect their autonomy as arrangements for
sample sharing and re-use are agreed upon during the in-
formed consent process. However, study participants felt the
issues of confidentiality are very central and place the re-
sponsibility to maintain privacy and confidentiality on the re-
searchers who collect samples. The study findings reveal that
while study participants may understand the reuse of storage
of samples, confidentiality was a top priority to them.
"As per communication, they said that when samples
are donated, they get them to the laboratory for
testing. And they exercise extreme confidentiality.
(FGD 442, Clinical Trial Research Participant).
This finding supports REC member’s concern that
broad consent undermines participant autonomy.
"..I have to consent to something that l fully understand
and l am aware in terms of what it is and its usage.
And you are asking me to give you my consent, my
agreement if l am to use that kind of term, to something
l don’t know just for future, I don’t know what you are
going to do, to what l am giving out to you. And you
are saying you are obtaining consent. That is not true,
that is cheating, and it’s a lie (IDI 234, Regulator,).
Some Researchers regarded the current consenting model
as inappropriate as it restricts study participants’ rights to con-
sent for future use of their biological samples. REC members
expressed concerns about destroying biological samples after
single use that were contrary to current stipulated regulations.
REC members considered a few scenarios that may require re-
use, and stipulated that the prohibition might hinder the pro-
motion of science and that it fails to recognize the harm done
to research participants who donated the samples.
"I mean for the time being the problem is; let’s say you
have analyzed your data, you have done your research
and you have disposed your specimens, but your findings
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are suggesting that you could have looked at this and that
but you have gotten rid of the specimens. This time you
need to write another protocol and collect new specimens
and that could be a problem. (IDI 230, Researcher).
Views on research governance and oversight
"..Build local capacity and enhance oversight: Sci-
ence is evolving, therefore let us value the human
samples" (IDI232, Researcher).
The study also sought stakeholders’ views on governance
and oversight of samples that have been collected. Re-
searchers and REC members expressed concerns on some of
the challenges and fears faced by both local researchers and
research oversight members that triggered the prevention of
collecting and reusing of samples for future research. Poten-
tial concerns included fear of exploitation of research sam-
ples when they have been sent to other collaborators or
researchers in other settings away from the primary collect-
ing points, lack of equipment or supplies to conduct robust
and comprehensive tests locally that necessitates exportation
of samples. Both researchers and REC members expressed
perceived feelings of mistrust towards researchers and
collaborators.
"… and I think that’s even true for researchers. I can
not 100% guarantee that the samples I am sending,
if I am not there they will be used for this particular
thing. I would rely on the trust of my colleagues.
Ethically you are always worried that if my
colleague or if my collaborator is not honest enough
they may want to use samples for something else
that I do not know. (IDI 222, Researcher).
Mistrust was reported in three categories; i) between
researchers obtaining consent and researchers in custody
of the samples after exportation, ii) between researchers
obtaining consent and institutions in custody of the left
over samples and iii) between study participants and re-
search institutions in custody of the samples.
"Because I really do push for all the samples to be ana-
lyzed here and I can name you researchers here well am
not going to but I could who I feel are almost like phar-
macists, which is bad. I mean they collect samples here
and somebody orders from the US and they say, I have
got that I will send it to you. That is completely inappro-
priate, the researchers here are just like middle men and
they are doing nothing for infrastructure, they are doing
nothing to train local Malawians, they are not bringing
in the machines etc. they are just collecting samples
and sending out. … …. There is really very few assays
that I fell we can’t do here at []., I mean I can count
on one hand the number of assays that I feel need to
be done outside, (IDI 223, Researcher).
In responding to a question on how issues of mistrust
could be addressed, almost all interviewees proposed
building local human and infrastructure capacity to con-
duct tests locally, promotion of good research practices
by research institutions, establishing legal and ethical
frameworks to provide guidance on sample handling,
participatory engagement in the review and revision of
ethical guidelines, promotion of effective research gov-
ernance and introduction of a legal stance on research
misconduct.
"I must admit I find it quite difficult, but I haven’t
looked at the more comprehensive guidelines from
the NCST. It’s not easy to access them. I think the
statement about duration of storage and what to do
with the samples after that is too prescriptive and
really does not appreciate the value of these human
samples in the context of moving science forward so
my view would be that if we are going to draft any
future guidelines we should look at the trend at
which science is going and we should value the
human samples that we collect". (IDI 222
Researcher, Southern Region).
Nevertheless, researchers cautioned that while it is
their responsibility to safeguard the quality of biological
samples and ensure informed consent, research over-
sight bodies have a core responsibility to serve as custo-
dians of biological samples collected from research. It
was widely recommended that research oversight bodies
must engage with relevant research stakeholders during
policies and guideline formulation.
"Consultation processes can be done, maybe coming
up with a committee which could look at this. a
committee can help because they are going to be
looking at the internal capacity of Malawi as well as
external challenges or balancing the two between
our capacity if we do not have that capacity what
can we do, how can we handle samples (IDI 221,
REC Member, Central Region).
These responses reflect the ethical and practical issues
that are inter-related to all research stakeholders in
Malawi. The solutions and concerns further highlight
the absence of the social relationship between REC
members and researchers in working towards the com-
mon goal of advancing science whilst at the same time
achieving high ethical standards. Lack of comprehensive
and robust strategies to offset various ethical concerns
remain unaddressed.
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Discussion
This study revealed a wide range of ethical and practical
issues that emerge from the current practice of collect-
ing, storing and reusing biological samples for additional
future research purposes in Malawi. Challenges and op-
portunities of the current informed consent models and
current guidelines were also discussed. The study re-
vealed respondents’ important divergent views based on
their roles and obligations and their years of experience
in the research community (for example, a REC mem-
ber, a regulator or researcher). It was also further noted
that study participants had differences in opinion based
on their experiences and relationship with research
institutions.
"… They are precious resources … so you want to
maximize their consent …"
In our analysis, almost all stakeholders widely supported
the practice of collecting, storing and reusing samples
for future research purposes. This is consistent with
existing literature [1, 3, 13, 14]. As mentioned earlier,
there is increase in biomedical research activities in
Malawi. However, this increase has been accompanied
by a large volume of biological samples and data being
exported to developed countries for analysis and future
use [15] instead of having such biological samples and
data stored in Malawi for future research.
In this study, the benefits of reusing samples were cat-
egorized into two: 1) reuse of samples offsets costs of
conducting primary research. Researchers widely sup-
ported this idea as they felt that it is very cost-effective
in a setting with limited human and financial resources
and 2) remnant samples were regarded as great re-
sources, useful during public health emergency research.
This category was widely supported by researchers and
REC members.
Exploitation and research participants protection
Concerns about the restrictive regulations and guidelines
that do not permit the reuse of samples for future research
has resulted in storage of samples by various institutions
with an expectation that guidelines maybe revised and sam-
ples could be re-used. This is reportedly a practice widely
exercised by research institutions in Africa [7] in spite of
the samples not being reused in future research. This is
against the principle of maximization of benefits and values
for biological samples and data collected from research par-
ticipants, defeating the principle of cost-effectiveness.
This study suggests that the regulation to prevent re-use
and collection of samples for future research is linked to
the overall fear of exploitation, lack of trust and transpar-
ency and engagement within the research community,
coupled with the uncertainty about what the regulation re-
quires in Malawi. Evidently, it is worth noting that these
problems are largely systemic and broadly cultural and his-
torical to some extent due to the export of samples. To ad-
dress these concerns, many stakeholders proposed the need
to establish a national biobank and an ethically robust gov-
ernance framework for biobanking. With more sensitization
and training about the scientific as well as ethical merits of
longitudinal storage of biological samples, and preserving
such collections within the country at institutional or na-
tional level, there is chance that these precious resources of
donated biological samples will be maintained and used to
promote the health and welfare of local residents.
The ethical and practical concerns expressed in this
study are in agreement with literature on various percep-
tions of sample collection, storage and reuse for future re-
search in Africa [1, 3, 13, 16]. As stipulated by various
authors, these concerns reveal how low and middle in-
come settings such as Malawi are struggling with develop-
ment of guidance documents that respond to ethical
issues emerging from advances in science and technology,
and also development of fair and effective collaborations.
The findings of the study highlight the dilemma among
stakeholders in Malawi in balancing the protection of
study participants and the need to advance science. It is
clearly evident that most stakeholders recognize the im-
portance of reusing samples but the historical and emer-
ging ethical issues are a stumbling block. The responses
clearly indicate that there are currently no approaches to
safeguard the welfare of research subjects apart from the
informed consent models and research oversight responsi-
bilities. This raises issues of respect for autonomy and
protection of study participants as ethical issues that re-
quire serious consideration in determining roles and re-
sponsibilities and defining obligations that come with
every role in protecting study participants.
Informed consent models for future use of samples
The findings of the study highlight key challenges to safe-
guarding the rights and welfare of research participants re-
garding the appropriate informed consent models for the
collection, storage and reuse of samples for future research
purposes. For example, some researchers strongly expressed
concern on the use of broad consent while on the other hand
REC members strongly refuted the use of broad consent but
rather opted for a more generic specific informed consent
model that gives study participants capacity to consent for
specific future use or to opt out. This finding is in agreement
with research conducted by Jantina et al. [7] who stipulated
that broad consent guidance documents in Malawi are non-
permissible. In view of this lack of permission for broad con-
sent in the regulations of Malawi, we recommend a revision
of the current guidelines and regulations to allow broad con-
sent in its current research practice and to be consistent with
current research practice worldwide. This recommendation is
highlighted in the recommendation section of this paper.
Matandika et al. BMC Medical Ethics           (2020) 21:61 Page 8 of 10
Most study participants were supportive of specific con-
sent while some indicated the need to be re-contacted for
future use of their biological samples and data. Most study
participants also recommended that they should receive
feedback on any incidental findings pertaining to their
wellbeing that are medically actionable in Malawi. This
contrasts with a study conducted by Wendler et al. in
Uganda who reported that most participants supported
that they should not be re-contacted for future use of their
biological samples and data thereby supporting broad con-
sent for collection of biological samples and data [17].
This study did reveal that study participants were support-
ive of broad consent on condition that confidentiality of
their results will be assured and they gave this responsibil-
ity to the researcher.
Our study highlights an important policy requirement for
researchers to provide feedback of research findings to re-
search participants. The community engagement guidelines
in Malawi require researchers to disseminate research find-
ings to research participants, their communities and policy
makers. Study participants hinted return of research results
is an important benchmark for engaging research partici-
pants, for promoting trust and transparency and for demon-
strating respect for persons among prospective sample
donors. Promising to return research results as a part of con-
sent process provides “return of value” to sample donors and
it is an essential aspect of a robust governance framework.
The use of the current informed consent model that
protects study participants from future unknown harm
was seen as both unethical and practically problematic
for settings with limited resources such as Malawi. Lack
of guidelines and reuse restrictions were similarly seen
as unethical and related to prohibiting an exercise to
personal autonomy as previously reported in Malawi [3].
However, in this study, study participants do trust re-
searchers to abide by various good research practices
outlined in informed consent procedures, for example,
issues of confidentiality and sample use.
The findings of this study reveal concerns among
REC members and local researchers on the fate of
samples collected and shipped outside the country
since both REC members and local researchers do
not have control over samples that have crossed the
borders. The concerns allude to the fact that bad re-
search practices cannot disappear in cross-border
collaborations especially where local RECs and re-
searchers lack capacity to oversee samples that are
exported in collaborative research. It was reported
that bad research practices could be dealt with by
participating institutions establishing good research
practices and policies that promote the welfare and
rights of research participants and giving ownership
rights to local researchers and local RECs where bio-
logical samples are collected.
Conclusion and recommendations
In conclusion, this study has highlighted various ethical
and practical concerns arising from the practice of collec-
tion, storage and secondary use of biological samples in
future research. However, there are ethical and practical
issues that need to be underscored between researchers
and research oversight bodies in Malawi. Broadly speak-
ing, most stakeholders supported storage and future use
of biological samples. This was on the assumption that
current regulations on informed consent models and fu-
ture use of biological samples would be revised holistically
to take into consideration opinions of all key stakeholders,
including community members and current research
oversight systems which have been developed to cope with
the roles and responsibilities of protecting the welfare of
research participants that contribute biological samples.
Enhancement of research governance, building of social
relationships and participatory engagement approaches to
developing guidance documents are significant in helping
the research community understand values and roles each
research stakeholder upholds in order to ensure protec-
tion of study participants and advancement of science. It
is also imperative that research institutions value good re-
search practices and account for high ethical standards be-
tween researchers and research oversight bodies in
Malawi. Furthermore, the results indicate that strategy
that have been widely known as fundamental to human
research protection such as specific informed consent re-
quire supplementary strategies to be developed.
It is high time that current regulations on future use of
biological samples and consent models in Malawi were re-
vised to maximize the cost-effectiveness and benefits of
biological samples collected from Malawian research par-
ticipants, and to be consistent with current accepted re-
search practices worldwide. Therefore, we recommend the
revision of the current regulations in Malawi to allow use
of a broad consent in research practice. The permission
will call for the education of the general public about the
value and importance of broad consent which will eventu-
ally lead to the establishment of the first national biobank
in Malawi where researchers can deposit remnant tissue
samples after first use. The establishment of such a bio-
bank will require development of governance structures
similar to those developed by the H3Africa. A potential
source of such funding is the H3Africa Consortium which
support establishment of biobanks in Africa through the
Wellcome Trust and the National Institutes of Health.
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